Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Antineoplastons are naturally occurring substances that may also be
made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. It is not yet
known whether giving antineoplastons with chemotherapy is more effective than chemotherapy
alone in treating women with refractory breast cancer.
PURPOSE: This randomized phase II trial is studying methotrexate alone to see how well it
works campared to methotrexate and antineoplaston therapy in treating postmenopausal women
with advanced refractory breast cancer.